Traws Pharma plans hantavirus treatment development amid cruise ship outbreak

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. ACN
2. NVDA
3. SPCX
4. MSTR
5. MU
6. RGA
7. APGE
8. ABBV
9. DFTX
10. BAUFF

Go back to Traws Pharma plans hantavirus treatment development amid cruise ship outbreak
(NASDAQ: TRAW) Delayed: 0.85 --0 (-0%)
Previous Close $0.85    52 Week High $ 
Open $0.85    52 Week Low $ 
Day High $0.85    P/E N/A 
Day Low $0.85    EPS $ 
Volume 8,869